Literature DB >> 20832487

Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD.

Prashanthi Vemuri1, Stephen D Weigand, David S Knopman, Kejal Kantarci, Bradley F Boeve, Ronald C Petersen, Clifford R Jack.   

Abstract

OBJECTIVE: When using imaging to predict time to progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD), time-to-event statistical methods account for varying lengths of follow-up times among subjects whereas two-sample t-tests in voxel-based morphometry (VBM) do not. Our objectives were to apply a time-to-event voxel-based analytic method to identify regions on MRI where atrophy is associated with significantly increased risk of future progression to AD in subjects with MCI and to compare it to traditional voxel-level patterns obtained by applying two-sample methods. We also compared the power required to detect an association using time-to-event methods versus two-sample approaches.
METHODS: Subjects with MCI at baseline were followed prospectively. The event of interest was clinical diagnosis of AD. Cox proportional hazards models adjusted for age, sex, and education were used to estimate the relative hazard of progression from MCI to AD based on rank-transformed voxel-level gray matter density (GMD) estimates.
RESULTS: The greatest risk of progression to AD was associated with atrophy of the medial temporal lobes. Patients ranked at the 25th percentile of GMD in these regions had more than a doubling of risk of progression to AD at a given time point compared to patients at the 75th percentile. Power calculations showed the time-to-event approach to be more efficient than the traditional two-sample approach.
CONCLUSIONS: We present a new voxel-based analytic method that incorporates time-to-event statistical methods. In the context of a progressive disease like AD, time-to-event VBM seems more appropriate and powerful than traditional two-sample methods.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20832487      PMCID: PMC2997139          DOI: 10.1016/j.neuroimage.2010.09.004

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  32 in total

1.  Nonparametric permutation tests for functional neuroimaging: a primer with examples.

Authors:  Thomas E Nichols; Andrew P Holmes
Journal:  Hum Brain Mapp       Date:  2002-01       Impact factor: 5.038

2.  Nonparametric tests of association between survival time and continuously measured covariates: the logit-rank and associated procedures.

Authors:  J O'Quigley; R L Prentice
Journal:  Biometrics       Date:  1991-03       Impact factor: 2.571

3.  Mayo Clinic Alzheimer's Disease Patient Registry.

Authors:  R C Petersen; E Kokmen; E Tangalos; R J Ivnik; L T Kurland
Journal:  Aging (Milano)       Date:  1990-12

4.  Tutorial in biostatistics: competing risks and multi-state models.

Authors:  H Putter; M Fiocco; R B Geskus
Journal:  Stat Med       Date:  2007-05-20       Impact factor: 2.373

5.  Efficiency of the logistic regression and Cox proportional hazards models in longitudinal studies.

Authors:  I Annesi; T Moreau; J Lellouch
Journal:  Stat Med       Date:  1989-12       Impact factor: 2.373

6.  Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Authors:  D P Devanand; G Pradhaban; X Liu; A Khandji; S De Santi; S Segal; H Rusinek; G H Pelton; L S Honig; R Mayeux; Y Stern; M H Tabert; M J de Leon
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

Review 7.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

8.  Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

Authors:  W J P Henneman; J D Sluimer; J Barnes; W M van der Flier; I C Sluimer; N C Fox; P Scheltens; H Vrenken; F Barkhof
Journal:  Neurology       Date:  2009-03-17       Impact factor: 9.910

9.  MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.

Authors:  J L Whitwell; M M Shiung; S A Przybelski; S D Weigand; D S Knopman; B F Boeve; R C Petersen; C R Jack
Journal:  Neurology       Date:  2007-09-26       Impact factor: 9.910

10.  The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.

Authors:  Akram Bakkour; John C Morris; Bradford C Dickerson
Journal:  Neurology       Date:  2008-12-24       Impact factor: 9.910

View more
  14 in total

1.  Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease.

Authors:  Lubov E Zeifman; William F Eddy; Oscar L Lopez; Lewis H Kuller; Cyrus Raji; Paul M Thompson; James T Becker
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Whole-brain analysis reveals increased neuroanatomical asymmetries in dementia for hippocampus and amygdala.

Authors:  Christian Wachinger; David H Salat; Michael Weiner; Martin Reuter
Journal:  Brain       Date:  2016-10-10       Impact factor: 13.501

3.  Discriminating Alzheimer's disease progression using a new hippocampal marker from T1-weighted MRI: The local surface roughness.

Authors:  Carlos Platero; María Eugenia López; María Del Carmen Tobar; Miguel Yus; Fernando Maestu
Journal:  Hum Brain Mapp       Date:  2018-11-19       Impact factor: 5.038

4.  Event time analysis of longitudinal neuroimage data.

Authors:  Mert R Sabuncu; Jorge L Bernal-Rusiel; Martin Reuter; Douglas N Greve; Bruce Fischl
Journal:  Neuroimage       Date:  2014-04-13       Impact factor: 6.556

5.  Assessing corpus callosum changes in Alzheimer's disease: comparison between tract-based spatial statistics and atlas-based tractography.

Authors:  Maria Giulia Preti; Francesca Baglio; Maria Marcella Laganà; Ludovica Griffanti; Raffaello Nemni; Mario Clerici; Marco Bozzali; Giuseppe Baselli
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

6.  Prediction of Mild Cognitive Impairment Conversion Using a Combination of Independent Component Analysis and the Cox Model.

Authors:  Ke Liu; Kewei Chen; Li Yao; Xiaojuan Guo
Journal:  Front Hum Neurosci       Date:  2017-02-06       Impact factor: 3.169

7.  Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patients.

Authors:  Eric R Braverman; Kenneth Blum; Uma J Damle; Mallory Kerner; Kristina Dushaj; Marlene Oscar-Berman
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

8.  Neuroinflammation and brain functional disconnection in Alzheimer's disease.

Authors:  Francesca Baglio; Marina Saresella; Maria Giulia Preti; Monia Cabinio; Ludovica Griffanti; Ivana Marventano; Federica Piancone; Elena Calabrese; Raffaello Nemni; Mario Clerici
Journal:  Front Aging Neurosci       Date:  2013-11-25       Impact factor: 5.750

9.  Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment.

Authors:  Mara Ten Kate; Frederik Barkhof; Pieter Jelle Visser; Charlotte E Teunissen; Philip Scheltens; Wiesje M van der Flier; Betty M Tijms
Journal:  Alzheimers Res Ther       Date:  2017-09-12       Impact factor: 6.982

10.  Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment.

Authors:  Jung-Min Pyun; Young Ho Park; Hang-Rai Kim; Jeewon Suh; Min Ju Kang; Beom Joon Kim; Young Chul Youn; Jae-Won Jang; SangYun Kim
Journal:  Alzheimers Res Ther       Date:  2017-12-16       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.